ITI-214
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ITI-214, covering 2015-02-19 to 2020-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure [Phase 1, Phase 2]